Victory Capital Management Inc. Purchases 33,161 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Victory Capital Management Inc. lifted its holdings in Definitive Healthcare Corp. (NASDAQ:DH) by 6.5% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 542,170 shares of the company’s stock after purchasing an additional 33,161 shares during the quarter. Victory Capital Management Inc.’s holdings in Definitive Healthcare were worth $2,424,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Bleakley Financial Group LLC acquired a new position in shares of Definitive Healthcare during the 3rd quarter worth about $74,000. SG Americas Securities LLC acquired a new stake in Definitive Healthcare during the third quarter worth approximately $84,000. Sanctuary Advisors LLC bought a new position in shares of Definitive Healthcare in the second quarter worth $85,000. Canada Pension Plan Investment Board bought a new stake in shares of Definitive Healthcare during the 2nd quarter worth approximately $109,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Definitive Healthcare by 31.4% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock worth $116,000 after purchasing an additional 5,083 shares during the last quarter. Institutional investors and hedge funds own 98.67% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Barclays dropped their price target on Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 7th. Robert W. Baird cut their price objective on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a report on Friday, November 8th. Finally, Morgan Stanley lowered their price objective on Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating for the company in a research report on Tuesday, August 6th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, Definitive Healthcare has an average rating of “Hold” and a consensus target price of $5.81.

Definitive Healthcare Stock Performance

DH stock opened at $4.37 on Monday. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. The firm has a market cap of $504.84 million, a PE ratio of -1.41, a P/E/G ratio of 3.13 and a beta of 1.33. The business has a 50 day moving average of $4.35 and a 200-day moving average of $4.81. Definitive Healthcare Corp. has a 12-month low of $3.19 and a 12-month high of $10.62.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.